GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Brain Scientific Inc (OTCPK:BRSF) » Definitions » Enterprise Value

Brain Scientific (Brain Scientific) Enterprise Value : $3.05 Mil (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Brain Scientific Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Brain Scientific's Enterprise Value is $3.05 Mil. Brain Scientific's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 was $-7.42 Mil. Therefore, Brain Scientific's EV-to-EBIT ratio for today is -0.41.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Brain Scientific's Enterprise Value is $3.05 Mil. Brain Scientific's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 was $-6.59 Mil. Therefore, Brain Scientific's EV-to-EBITDA ratio for today is -0.46.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Brain Scientific's Enterprise Value is $3.05 Mil. Brain Scientific's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was $0.21 Mil. Therefore, Brain Scientific's EV-to-Revenue ratio for today is 14.24.


Brain Scientific Enterprise Value Historical Data

The historical data trend for Brain Scientific's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain Scientific Enterprise Value Chart

Brain Scientific Annual Data
Trend Dec21 Dec22
Enterprise Value
- 12.68

Brain Scientific Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Enterprise Value Get a 7-Day Free Trial - - 15.99 12.28 12.68

Competitive Comparison of Brain Scientific's Enterprise Value

For the Medical Devices subindustry, Brain Scientific's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brain Scientific's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Brain Scientific's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Brain Scientific's Enterprise Value falls into.



Brain Scientific Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Brain Scientific's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

Brain Scientific's Enterprise Value for the quarter that ended in Dec. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brain Scientific  (OTCPK:BRSF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Brain Scientific's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3.048/-7.415
=-0.41

Brain Scientific's current Enterprise Value is $3.05 Mil.
Brain Scientific's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.42 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Brain Scientific's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=3.048/-6.591
=-0.46

Brain Scientific's current Enterprise Value is $3.05 Mil.
Brain Scientific's EBITDA for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.59 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Brain Scientific's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3.048/0.214
=14.24

Brain Scientific's current Enterprise Value is $3.05 Mil.
Brain Scientific's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brain Scientific Enterprise Value Related Terms

Thank you for viewing the detailed overview of Brain Scientific's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Brain Scientific (Brain Scientific) Business Description

Traded in Other Exchanges
N/A
Address
6700 Professional Parkway, Lakewood Ranch, FL, USA, 34240
Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
Executives
Morgan C. Frank 10 percent owner 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02110
Manchester Explorer, L.p. 10 percent owner MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
James E Besser 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114
Jeb Partners, L.p. 10 percent owner MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Management Pr, Llc 10 percent owner 3 WEST HILL PLACE, BOSTON MA 02114
Donald S Mackenzie director 5251 FISHER ISLAND DRIVE, MIAMI BEACH FL 33109
Thomas Olivier director C/O ARROWROOT ACQUISITION CORP., 4553 GLENCOE AVE SUITE 200, MARINA DEL REY CA 90292
Farid Anthony officer: Chief Technology Officer 12041 NW 49TH DRIVE, CORAL SPRINGS FL 33076
Daniel Danny Cloutier director 1200 MC GILL COLLEGE AVENUE, SUITE 1100, MONTREAL A8 H3G4G7
Bonnie-jeanne Gerety officer: Chief Financial Officer 5255 SOUTH TRIMBLE RD, SANDY SPRINGS GA 30342
Hassan Kotob director, 10 percent owner, officer: Chief Executive Officer 125 WILBUR PLACE, SUITE 170, C/O BRAIN SCIENTIFIC INC., BOHEMIA NY 11716
Mark Corrao officer: Chief Financial Officer 531 AIRPORT NORTH OFFICE PARK, FORT WAYNE IN 46825
Boris Goldstein director, 10 percent owner, officer: Chairman of the Board & EVP 45 WEST34 ST. 800, NEW YORK NY 10001
Nickolay V. Kukekov director 4524 WESTWAY AVE, DALLAS TX 75205

Brain Scientific (Brain Scientific) Headlines